Cell Signaling Technology, Ventana Ink Deal for EGFR Detection Technology

The deal covers patent rights and antibody reagents related to the detection of EGFR mutations for tissue-based in vitro diagnostics testing.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories